Laden...
Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH). MERS antibodies produced in cattle safe, treatment well tolerated in Phase 1 trial 01/10/2018 08:00 AM ESTSince 2012, the MERS coronavirus has spread to 27 countries and sickened more than 2,000 people Update Your E-mail Address | Add Subscriptions | Unsubscribe If you have questions or problems with the subscription service, please contact subscriberhelp.govdelivery.com. For all other inquiries about NIH programs and activities, please contact [email protected]. Before writing, please view ourFrequently Asked Questions page, our Health Information page, or Search our website. This service is provided to you by the National Institutes of Health.
|
Laden...
Laden...